198 related articles for article (PubMed ID: 16414229)
1. Focal nodular hyperplasia.
Vilgrain V
Eur J Radiol; 2006 May; 58(2):236-45. PubMed ID: 16414229
[TBL] [Abstract][Full Text] [Related]
2. Focal nodular hyperplasia within accessory liver: imaging findings at computed tomography and magnetic resonance imaging.
Dreizin D; Infante J; Tirada N; Raman SP; Madrazo B
J Comput Assist Tomogr; 2014; 38(3):424-6. PubMed ID: 24651749
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
4. Investigating focal liver lesions.
Patel DV; Scott V; Pilcher J
BMJ; 2012 Feb; 344():e657. PubMed ID: 22318436
[No Abstract] [Full Text] [Related]
5. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
Fröhlich JM
J Magn Reson Imaging; 2004 Mar; 19(3):375-6; author reply 376. PubMed ID: 14994308
[No Abstract] [Full Text] [Related]
6. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
7. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.
Marin D; Brancatelli G; Federle MP; Lagalla R; Catalano C; Passariello R; Midiri M; Vilgrain V
Clin Radiol; 2008 May; 63(5):577-85. PubMed ID: 18374723
[TBL] [Abstract][Full Text] [Related]
8. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.
Grazioli L; Morana G; Federle MP; Brancatelli G; Testoni M; Kirchin MA; Menni K; Olivetti L; Nicoli N; Procacci C
Radiology; 2001 Dec; 221(3):731-9. PubMed ID: 11719669
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
Fowler KJ; Brown JJ; Narra VR
Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
[TBL] [Abstract][Full Text] [Related]
10. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
11. MRI of intralesional hemolysis in focal nodular hyperplasia of the liver.
Mahfouz AE; Rahmouni A; Terem C; Cherqui D; Mathieu D; Chariot P; Nhieu JT; Vasile N
J Comput Assist Tomogr; 1999; 23(5):684-6. PubMed ID: 10524845
[TBL] [Abstract][Full Text] [Related]
12. Focal nodular hyperplasia: intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging.
Marin D; Iannaccone R; Laghi A; Catalano C; Murakami T; Hori M; Kim T; Passariello R
J Magn Reson Imaging; 2007 Apr; 25(4):775-82. PubMed ID: 17348002
[TBL] [Abstract][Full Text] [Related]
13. Focal nodular hyperplasia of the liver: diffusion-weighted magnetic resonance imaging characteristics using high b values.
Dohan A; Soyer P; Guerrache Y; Hoeffel C; Gavini JP; Kaci R; Boudiaf M
J Comput Assist Tomogr; 2014; 38(1):96-104. PubMed ID: 24424559
[TBL] [Abstract][Full Text] [Related]
14. [Benign focal hepatic lesions].
Baroud S; Bastati N; Prosch H; Schima W; Ba-Ssalamah A
Radiologe; 2011 Aug; 51(8):688-96. PubMed ID: 21809146
[TBL] [Abstract][Full Text] [Related]
15. [Focal nodular hyperplasia of liver].
Luk'ianchenko AB; Medvedeva BM; Shabanov MA; Luk'ianchenko KA
Vestn Rentgenol Radiol; 2013; (3):61-8. PubMed ID: 25669079
[No Abstract] [Full Text] [Related]
16. Natural course of hepatic focal nodular hyperplasia: a long-term follow-up study with sonography.
Kuo YH; Wang JH; Lu SN; Hung CH; Wei YC; Hu TH; Chen CH; Yen YH; Lee CM; Eng HL
J Clin Ultrasound; 2009; 37(3):132-7. PubMed ID: 18855931
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver.
Janica J; Serwatka W; Polaków J; Ustymowicz A; Walecki J; Ladny JR; Dobrzycki S
Med Sci Monit; 2004 Jun; 10 Suppl 3():17-21. PubMed ID: 16538193
[TBL] [Abstract][Full Text] [Related]
18. Hepatic focal nodular hyperplasia: the "star sign" on gadolinium-enhanced magnetic resonance angiography.
Ko SF; Ng SH; Lee TY; Wan YL; Lin JW; Chen CL
Hepatogastroenterology; 2002; 49(47):1377-81. PubMed ID: 12239946
[TBL] [Abstract][Full Text] [Related]
19. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Grazioli L; Morana G; Kirchin MA; Schneider G
Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
